Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oncothyreon -- Ignore unavailable to you. Want to Upgrade?

To: StockMiser who wrote (610)	4/29/1999 10:14:00 AM
From: Michael Brody	Respond to of 2344

SM, Thank you for your thoughtful analysis of the questions posed to you. I would just EMPHASIZE that Media coverage is crucial to the upward mobility of BIOM. As you point out great science can mean little to a stock's price without sufficient public awareness of the results being generated. Another major factor which is often forgotten is the overall condition of the Market (which right now appears positive). A great stock in a lousy market can still go nowhere. Finally, I wonder if you or others might be able to adress two points: 1) What are the actual parameters of success for Theratope in the current studies ? i.e., You mentioned Median Survival Rate. Is this the primary scientific measuring stick, or are there other equally important numbers,etc. ? 2) Can you provide a little more info. on what BLP-25 is designed to do ?